SCHEMBL1886006

SCHEMBL1886006

C[N+]1(C(Br)CCCCCCCCCCC(Br)[N+]2(C)CCCC2)CCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2908299 0.98
SCHEMBL419422 0.95
SCHEMBL4798792 0.93
SCHEMBL923192 0.91
SCHEMBL3266202 0.89
SCHEMBL15053253 0.87
SCHEMBL16583998 0.87 LMNA (0.41)
SCHEMBL16767003 0.85
SCHEMBL14915157 0.84 LMNA (0.39)
SCHEMBL14914486 0.81 BBOX1 (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7947854-B2 Phospholipase inhibitor; prevention or therapy of microbial infection; bactericides; fungicides; viricides; parasiticides; using quaternary or phosphonium group containing compounds THE UNIVERSITY OF SYDNEY (AU) 2011-05-24 US disclosed
US-20080275003-A1 Bis-Cationic Compounds and Use Thereof THE UNIVERSITY OF SYDNEY (AU) 2008-11-06 US disclosed
EP-1689698-A4 BIS-CATIONIC COMPOUNDS AND USE THEREOF UNIV SYDNEY (AU) 2007-09-05 EP disclosed
EP-1689698-A1 BIS-CATIONIC COMPOUNDS AND USE THEREOF THE UNIVERSITY OF SYDNEY (AU) 2006-08-16 EP disclosed
WO-2005047230-A1 BIS-CATIONIC COMPOUNDS AND USE THEREOF THE UNIVERSITY OF SYDNEY (AU) 2005-05-26 WO disclosed